As published in Frontiers in Pharmacology, the biopharmaceutical drug development firm's sponsored research has identified and validated cannabinoid ratio-controlled, Minimum Essential Mixtures (MEM) for the treatment of Parkinson's disease symptoms
Read Press ReleaseAccording to Chris Powell of Consumer Safety Watch, the vote was 84-14 Thursday to pass the Honoring Our PACT Act, H.R. 3967 (117), requiring broadened Department of Veterans Affairs coverage for toxic exposure related to burn pits and contaminated water
Read Press ReleaseThe appointment is set to increase area resources and further elevate awareness of the disease, which has impacted the Pinegar family
Read Press ReleaseElderHealth is a geriatric medical practice and virtual doctors office now accepting new patients in the Tucson, Marana, and Oro Valley areas.
Read Press ReleaseThis marks the 11th U.S. provisional patent application filed by GBS covering the use of CCCM™ for unique medical disorders, creating an IP portfolio that contains formulas for up to 50 potential therapeutic indications.
Read Press ReleaseMr. Riley to Lead Corporate Development Efforts as Company Targets New Clinical Applications for its Proprietary, FDA-Cleared Blink Reflex Technology
Read Press ReleaseThis is the first time a Cannabinoid-Containing Complex Mixture (CCCM™) has been awarded a U.S. patent, which thereby validates GB Sciences' drug discovery platform and strengthens its intellectual property patent portfolio
Read Press ReleaseGBS Global Biopharma, Inc., the Canadian holding of GB Sciences, signed an Amendment to their Agreement with the National Research Council of Canada (NRC) to include valuable testing of Mechanism of Action for its Parkinson's Disease (PD) Formulations to strengthen their Investigational New Drug (IND) Application to the US FDA in preparation for human trials addressing a $52 billion market in the US alone.
Read Press ReleaseStudy aims to identify novel blood-based inflammatory markers that can be used to both identify and stratify Parkinson's disease patients
Read Press ReleaseRecently, in two research papers published in the journal Cell and Neuron, scientists at the Gladstone institutes found special neural circuits controlling walking through the study. At the same time, they also found that the circuit input was interrupted in Parkinson's disease patients.
Read Press ReleaseA Canadian based non-profit organization, World Parkinson's Program, held a seminar in Delhi, India to lecture about Parkinson's disease. The lectures included multiple topics, and included a question and answer period. Those who attended included physicians, neurologists and other healthcare professionals from India.
Read Press ReleaseWorld Parkinson's Program announces the continuation of its' "Fall Prevention Campaign" by delivering educational material to Africa Parkinson's Association. The material will aid those who suffer from Parkinson's disease and would not be able to afford healthcare supplies otherwise.